The aim of the present work was to evaluate the usefulness of the interferon-gamma release assays (IGRAs): QuantiFERON-tuberculosis (TB) Gold-In-Tube test (QFG) and T-SPOT.TB for the diagnosis of ...

QuantiFERON TB (QFT) was the first interferon gamma release assay (IGRA) utilizing whole blood stimulation as a test for TB infection, gaining FDA approval in 2001. Subsequently there have been ...

“QuantiFERON has transformed latent tuberculosis testing, and we will always take the necessary legal steps to defend our proprietary technologies against infringement.” This legal action ...

Qiagen (NYSE:QGEN) shares traded higher on Monday after the Dutch diagnostics company issued its preliminary Q1 2021 ...

Qiagen (QGEN) shares up premarket after disclosing strong preliminary Q1 2025 results and raising full-year EPS outlook.

Sales of the QuantiFERON latent TB test grew about 15% CER as global adoption continues to shift from the skin test to this ...

including T-SPOT and QuantiFERON tests* *QuantiFERON tests are available without an appointment on the second floor of Wardenburg Health Center during business hours. TB testing services are typically ...

Venlo, the Netherlands, April 6, 2025 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces preliminary Q1 2025 results that exceed the outlook for both net sales and adjusted earnings ...

and the TB Screening Questionnaire or proof of negative TB Test within last 12 months, which can include PPD Skin Test, T-Spot Lab Test, or Quantiferon Gold Lab Test. These health forms are required ...

Given the positive start to 2025, QIAGEN is raising its adjusted diluted EPS outlook for full-year 2025 in light of the strong sales growth in Q1 and the overall current business trends, which ...